Silver Pegasus Acquisition
SPEGU · NASDAQ
About SPEGU
- Employees
- 0
- Headquarters
- Santa Clara, California
- Listed
- Jul 15, 2025
- Sector
- N/A
- Industry
- N/A
SPEGU key statistics
- Market cap
- 160.69M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 13
- Volume
- 300
- Open price
- $10.55
- High today
- $10.55
- Low today
- $10.55
- 52 Week high
- $13.66
- 52 Week low
- $10.23
Silver Pegasus Acquisition (SPEGU) at a glance
As of Nov 16, 2026, Silver Pegasus Acquisition (SPEGU) shares are priced at $10.55, giving the company a market cap of 160.69M and a price-to-earnings ratio of 0.00.
Volume so far is 300 shares, above the average of 13 shares a day.
Over the past year Silver Pegasus Acquisition has ranged from $10.23 to $13.66, and now sits 9% of the way up that range.
SPEGU news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Silver Pegasus Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering
Most active stocks
Highest trading volume today
- RDARRaadr$0.0002+0.00%
- CYABCyabra$0.1368+53.71%
- NVDANVIDIA$156.14−4.12%
- RWAXTAP Real Estate Technologies$0.0001−50.00%
- DVLTDatavault AI$0.028−53.33%
- IFXYInfrax Systems$0.0005−16.67%
- SHFSSHF Holdings$0.023−24.09%
- TIPSTianrong Internet Products & Services$0.0007+16.67%
- SOXLDirexion Shares ETF Trust$48.76−16.39%
- AXXAExxe Group$0.0004−12.50%
- EARIEntertainment Arts Research$0.0002+0.00%
- GDHGGolden Heaven Group Holdings$1.58+91.45%
Newly listed
Companies that went public in the past six weeks
- NARANarragansett Bancorp$10.48−1.13%
- ASPEAspen Neuroscience$12.23−2.86%
- BBTXBambusa Therapeutics$15.98−0.68%
- GBCGEORGIA BANKING$34.48+1.08%
- BHAIUBHAV Acquisition Corp II$10.02+0.10%
- SCQCUSPACCircle Acquisition$10.01−0.10%
- LYCALycia Therapeutics$28.61−8.30%
- DAVIDAVION HEALTHCARE$1.02+2.00%
- TCXBTCGX Acquisition Corp. II$10.25+0.89%
- CTYCITY THERAPEUTICS$16.98−6.19%
- IAMIambic Therapeutics$11.85−9.54%
- AMROAmaero$5.63+2.36%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.